Moghadam, E.R.; Ang, H.L.; Asnaf, S.E.; Zabolian, A.; Saleki, H.; Yavari, M.; Esmaeili, H.; Zarrabi, A.; Ashrafizadeh, M.; Kumar, A.P.
Broad-Spectrum Preclinical Antitumor Activity of Chrysin: Current Trends and Future Perspectives. Biomolecules 2020, 10, 1374.
https://doi.org/10.3390/biom10101374
AMA Style
Moghadam ER, Ang HL, Asnaf SE, Zabolian A, Saleki H, Yavari M, Esmaeili H, Zarrabi A, Ashrafizadeh M, Kumar AP.
Broad-Spectrum Preclinical Antitumor Activity of Chrysin: Current Trends and Future Perspectives. Biomolecules. 2020; 10(10):1374.
https://doi.org/10.3390/biom10101374
Chicago/Turabian Style
Moghadam, Ebrahim Rahmani, Hui Li Ang, Sholeh Etehad Asnaf, Amirhossein Zabolian, Hossein Saleki, Mohammad Yavari, Hossein Esmaeili, Ali Zarrabi, Milad Ashrafizadeh, and Alan Prem Kumar.
2020. "Broad-Spectrum Preclinical Antitumor Activity of Chrysin: Current Trends and Future Perspectives" Biomolecules 10, no. 10: 1374.
https://doi.org/10.3390/biom10101374
APA Style
Moghadam, E. R., Ang, H. L., Asnaf, S. E., Zabolian, A., Saleki, H., Yavari, M., Esmaeili, H., Zarrabi, A., Ashrafizadeh, M., & Kumar, A. P.
(2020). Broad-Spectrum Preclinical Antitumor Activity of Chrysin: Current Trends and Future Perspectives. Biomolecules, 10(10), 1374.
https://doi.org/10.3390/biom10101374